Диссертация (1174357), страница 28
Текст из файла (страница 28)
– Vol. 22 (2). – P. 169-176.172339. Steroid receptor expressions in endometrial cancer: clinical significance andepidemiological implication / Y.T. Jeon [et al.] // Lett. – 2006. – Vol. 239 (2). – P. 198204.340. Stimulating the GPR30 Estrogen Receptor with a Novel TamoxifenAnalogue Activates SF-1 and Promotes Endometrial Cell Proliferation / B.C. Lin [et al.]// Cancer Res. – 2009. – Vol. 69 (13). – P.
5415–5423.341. Study on the relationship between estrogen receptor beta and etiology ofhuman endometrial polyps / H. Ye [et al.] // Zhonghua Fu Chan Ke Za Zhi. – 2006. –Vol. 41 (12). – P. 814-816.342. Subgroup of reproductive functions of progesterone mediated byprogesterone receptor-B isoform / B. Mulac-Jericevic [et al.] // Science. – 2000.
– Vol.289. – Р. 1751–1754.343. Suh-Burgmann, E. Complex atypical endometrial hyperplasia: the risk ofunrecognized adenokarcinoma and value of preoperative dilatation and curettage / E.Suh-Burgmann, Y.Y. Hung, M. Armstrong // Obstet. Gynaecol. – 2009. – Vol. 114 (3).– P. 523-529.344. Supervised clustering of immunohistochemical markers to distinguishatypical and non-atypical endometrial hyperplasia / E. Laas [et al.] // Gynecol.Endocrinol. – 2015. – Vol.
31 (4). – P. 282-285.345. Sutter-Dub, M. T. Rapid non-genomic and genomic responses toprogestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, theadipocyte and other cell types / M. T. Sutter-Dub // Steroids. – 2002. – Vol. 67 (2). – P.77-93.346. Tachev, S. Sex steroid receptors in atypical hyperplasia and endometrialcarcinoma / S. Tachev, G. Gorchev, G. Kynmyrjiev // Int. J.
Gynecol. Obstet. – 1994. –Vol. 46. – P. 63.347. Tamoxifen represses miR-200 microRNAs and promotes epithelial-tomesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines /J.X. Bai, [et al.] // Endocrinology. – 2013. – Vol. 154 (2). – P. 635-645.173348. Ten-year results of a prospective study on the prognostic role of ploidy inendometrial carcinoma / T. Susini [et al.] // Cancer. – 2007. – Vol.
109 (5). – P. 882890.349. TheAmericanCollegeofObstetriciansandGynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia /Committee on Gynecologic Practice, Society of Gynecologic Oncology // Obstet.Gynecol. – 2015. – Vol. 125 (5). – P. 1272-1278.350. The behavior of endometrial hyperplasia: a prospective study. EndometrialHyperplasia Study Group / N. Terakawa [et al.] // J. Obstet. Gynaecol. Res. – 1997. –Vol. 23 (3). – P. 223-230.351. The differential expression of oestrogen receptors, progesterone receptors,Bcl-2 and Ki67 in endometrial polyps / L.J. Taylor [et al.] // Bjog. – 2003.
– Vol. 110(9). – P. 794-798.352. The effect of medroxyprogesterone acetate on angiogenesisin complexendometrial hyperplasia / O. Abulafia [et al.] // Gynecol. Oncol. – 1999. – 72 (2). – P.193-198.353. The effectiveness of a levonorgestrel-releasing intrauterine system (LNGIUD) in the treatment of endometrial hyperplasia--a long-term follow-up study / R.Varma [et al.] // Eur.
J. Obstet. Gynecol. Reprod. Biol. – 2008. – Vol. 139 (2). – P. 169175.354. The expression of the hormone receptors in the endometrium andendometrial polyps in postmenopausal women and its relationship to body mass index /M.S. Belisario [et al.] // Maturitas. – 2006. – Vol. 53 (1). – P. 114-118.355. The opposing transcriptional activities of the two isoforms of the humanprogesterone receptor are due to differential cofactor binding / P.H. Giangrande [et al.]// Mol.
Cell Biol. – 2000. – Vol. 20 (9). – P. 3102-3115.356. The prevalence of endometrial hyperplasia and endometrial cancer inwomen with polycystic ovary syndrome or hyperandrogenism / N.S. Holm [et al.] //Acta Obstet. Gynecol. Scand. – 2012. – Vol. 91 (10). – P. 1173-1176.174357.
Therapeutic options for management of endometrial hyperplasia / V.Chandra [et al.] // J. Gynecol. Oncol. – 2016. – Vol. 27 (1). – P. e8.358. The role of preexisting diabetes mellitus on incidence and mortality ofendometrial cancer: a meta-analysis of prospective cohort studies / Z.H. Zhang [et al.] //Int. J. Gynecol. Cancer. – 2013.
– Vol. 23 (2). – P. 294-303.359. The rs1800716 variant in CYP2D6 is associated with an increased doubleendometrial thickness in postmenopausal women on tamoxifen / A.S. Dieudonne [et al.]// Ann. Oncol. – 2014. – Vol. 25 (1). – P. 90-95.360. Thomas, P. Characteristics of membrane progestin receptor alpha (mPRα)and progesterone membrane receptor component one (PGMRC1) and their roles inmediating rapid progestin actions / P.
Thomas // Front. Neuroendocrinol. – 2008. – Vol.29 (2). – P. 292–312.361. Thrombospondin-4 binds specifi cally to both collagenous and noncollagenous extracellular matrix proteins via its C-terminal domains / L. Narouz-Ott [etal.] // J. Biol. Chem. – 2000. – Vol. 275. – 37110-37117.362. Tissue microarray immunohistochemical expression analysis of mismatchrepair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrialhyperplasia: relationship with microsatellite instability / D. Hardisson [et al.] Mod.Pathol. – 2003. – Vol. 16 (11). – P.
1148-1158.363. TP53 mutations in human cancers: functional selection and impact on cancerprognosis and outcomes / A. Petitjean [et al.] // Oncogene. – 2007. – Vol. 26 (15). – P.2157–2165.364. Transcriptional cross talk between the forkhead transcription factor forkheadbox O1A and the progesterone receptor coordinates cell cycle regulation anddifferentiation in human endometrial stromal cells / M.Takano [et al.] // Mol.Endocrinol.
– 2007. – 21 (10). – P. 2334–2349.365. Transvaginal ultrasonography of the endometrium in women withpostmenopausal bleeding - a Nordic multicenter study / B. Karlsson [et al.] //AmericanJournal of Obstetrics and Gynecology. – 1995. – Vol. 172 (5). – P. 1488.175366. Treatment results of endometrial hyperplasia after prospective D-scoreclassification: a follow-up study comparing effect of LNG-IUD and oral progestinsversus observation only / A.
Ørbo [et al.] // Gynecol. Oncol. – 2008. – Vol. 111 (1). – P.68-73.367. Tumor expression of human growth hormone and human prolactin predict aworse survival outcome in patients with mammary or endometrial carcinoma / Z.S. Wu[et al.] // J. Clin. Endocrinol. Metab. – 2011. – Vol. 96 (10). – P. E1619-1629.368. Up-regulation of the progesterone receptor (PR)-C isoform in laboringmyometrium by activation of nuclear factor-κappaB may contribute to the onset of laborthrough inhibition of PR function / J.C.
Condon [et al.] // Mol. Endocrinol. – 2006. –Vol. 20 (4). – P. 764–775.369. Vascular effects of synthetic or natural progestagen combined withconjugated equine estrogen in healthy postmenopausal women / K.K. Koh [et al.] //Circulation. – 2001. – Vol. 103 (15). – P. 1961-1966.370. Vaskivuo, T.E.
Apoptosis and apoptosis-related factors Bcl-2, Bax, tumornecrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma/ T.E. Vaskivuo, F. Stenback, J.S. Tapanainen // Cancer. – 2002. – Vol. 95 (7). – P.1463-1471.371.
Vousden, K.H. p53 in health and disease / K.H. Vousden, D.P. Lane // Nat.Rev. Mol. Cell Biol. – 2007. – Vol. 8 (4). – P. 275-283.372. Well-differentiated endometrial adenocarcinomas and poorly differentiatedmixed mullerian tumors have altered ER and PR isoform expression / A.A. Jazaeri [etal.] // Oncogene. – 2001. – Vol. 20 (47).
– P. 6965-6969.373. World Health Organization - histologic typing of tumors of the femalegenital tract / Scully R.E. [et al.]. – Heidelberg, Springer-Verlag, 1994. – P. 26-28.374. Yang, S. Progesterone: the ultimate endometrial tumor suppressor / S. Yang,K.W. Thiel, K.K. Leslie // Trends Endocrinol. Metab. – 2011. – Vol. 22 (4). – P. 145152.176375. Zhang, D. Integration of membrane and nuclear estrogen receptor signaling /D. Zhang, V.L. Trudeau // Comp. Biochem. Physiol. A Mol. Integr. Physiol.
– 2006. –Vol. 144 (3). – P. 306-315.376. Zhao, C. Estrogen receptor beta: an overview and update / C. Zhao, K.Dahlman-Wright, J.A. Gustafsson // Nucl. Recept. Signal. – 2008. – Vol. 6. – P. e003.377. Zhu, L. Estradiol-17beta regulates mouse uterine epithelial cell proliferationthrough insulin-like growth factor 1 signaling / L.
Zhu, J.W. Pollard // Proc. Natl. Acad.Sci. U S A. – 2007. – Vol. 104 (40). – P. 15847-15851.378. Zitao, Liu. Steroid hormone receptor profile of premenopausal endometrialpolyps / Liu Zitao, S. Kuokkanen, L. Pal // Reprod. Sci. – 2010. – Vol. 17 (4). – P. 377383..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
